(Q37827914)

23 August 2017

Oncogenes and tumor suppressor genes in prostate cancer: a review (English)

1 reference

23 August 2017

1 reference

Wang YZ

1

1 reference

PubMed ID

21227058

23 August 2017

Wong YC

series ordinal

2

1 reference

23 August 2017

1 March 1997

1 reference

23 August 2017

1 reference

23 August 2017

3

1 reference

23 August 2017

2

1 reference

23 August 2017

41-46

1 reference

Oncogenes in prostate cancer. An update

23 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Infrequent RAS oncogene mutations in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Expression of ras oncogene p21 in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Immunohistochemical staining of ras p21: staining in benign and malignant prostate tissue

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Heterogeneous subpopulations of human prostatic adenocarcinoma cells: potential usefulness of P21 protein as a predictor for bone metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Mutational status of codons 12 and 13 of the N- and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Expression of cellular oncogenes in human prostatic carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Expression of ras proto-oncogenes in the Dunning R3327 rat prostatic adenocarcinoma system

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

ras, p53 and HPV status in benign and malignant prostate tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

State of adenomatous polyposis coli gene and ras oncogenes in Japanese prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Proto-oncogenes and tumor suppressor genes in human urological malignancies.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Immunohistochemical detection of oncogene proteins and neuroendocrine differentiation in different stages of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Enhanced expression of the c-myc protooncogene in high-grade human prostate cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Growth factor involvement and oncogene expression in prostatic tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

In situ expression of mRNA for proto-oncogenes in benign prostatic hyperplasia and in prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Amplification, rearrangement, and elevated expression of c-myc in the human prostatic carcinoma cell line LNCaP.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Recurrent cytogenetic alterations of prostate carcinoma and amplification of c-myc or epidermal growth factor receptor in subclones of immortalized PNT1 human prostate epithelial cell line.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Intranuclear androgen receptor deployment and protooncogene expression in human diseased prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Transcription factor encoding oncogenes.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Differential expression of transforming growth factor-?1 and ?3 as well as C-FOS mRNA in normal human prostate, benign prostatic hyperplasia and prostatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Transfected neu oncogene induces human prostate cancer metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

bl-2 [corrected] Expression on prostate cancer and its relationship to cell cycle and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Learning how to suppress cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Retinoblastoma gene mutations in primary human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Mutant p53 expression in prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Protein expression of p53, bcl-2, and KI-67 (MIB-1) as prognostic biomarkers in patients with surgically treated, clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Determining prognosis of clinically localized prostate cancer by immunohistochemical detection of mutant p53

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

P53 tumour-suppressor gene mutations are mainly localised on exon 7 in human primary and metastatic prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Recombinant adenovirus vector expressing wild-type p53 is a potent inhibitor of prostate cancer cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Quantitation of NM23 expression in human prostate tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

KAI1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

New clue to prostate cancer spread

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

Evidence for a tumor suppressor gene distal to BRCA1 in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1078-1439%2897%2900021-5

7 January 2021

10.1016/S1078-1439(97)00021-5

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

21227058